» Articles » PMID: 35069853

Effect of Src Tyrosine Kinase on a Rat Model of Asthma

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2022 Jan 24
PMID 35069853
Authors
Affiliations
Soon will be listed here.
Abstract

Src tyrosine kinase is a protein encoded by the Src gene. The present study aimed to determine the role of Src protein kinase in asthma using small interfering RNA (siRNA) technology. Several Src siRNAs were designed and the most effective siRNA pair was selected. A rat model of asthma was established using ovalbumin, and the rats were treated with Src siRNA, empty vector or phosphate-buffered saline (PBS). A non-asthmatic control group was also established. The rats were clinically observed and Src mRNA and protein levels were measured by reverse transcription-quantitative PCR and western blot analysis, respectively. Pathological observation of the lung tissue, counting of white blood cells (WBCs) and eosinophils (EOSs) and analysis of the concentrations of IL-5, IL-33 and IFN-γ in the bronchoalveolar lavage fluid were performed. The expression levels of Src mRNA in the control, PBS, empty vector and siRNA groups were 110±30.7x10, 253±55.4x10, 254±41.3x10 and 180±50.9x10, respectively. Histochemical analysis of the lung tissue of rats in the siRNA group exhibited a relatively complete lung structure and little damage to the alveolar cavity. Src protein expression and IL-5, IL-33 levels, WBC and EOS levels were positively correlated with Src mRNA expression, while the IFN-γ concentration was negatively correlated with Src mRNA expression. These results indicate that Src knockdown inhibits the release of tracheal inflammatory factors and significantly alleviates asthma in rats. In conclusion, the present study utilized a gene transfer technique to interfere with the expression of Src in rats, which decreased the levels of IL-5, IL-33, WBCs and EOSs and increased the level of IFN-γ; these changes effectively ameliorated the condition of the trachea in asthmatic rats.

Citing Articles

Lonicerin attenuates house dust mite-induced eosinophilic asthma through targeting Src/EGFR signaling.

Deng Z, Zhang X, Wen J, Yang X, Xue L, Ou C Front Pharmacol. 2023; 13:1051344.

PMID: 36618942 PMC: 9817108. DOI: 10.3389/fphar.2022.1051344.


Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.

Zhang Y, Almazi J, Ong H, Johansen M, Ledger S, Traini D Int J Mol Sci. 2022; 23(5).

PMID: 35269550 PMC: 8909959. DOI: 10.3390/ijms23052408.

References
1.
Strasner A, Natarajan M, Doman T, Key D, August A, Henderson A . The Src kinase Lck facilitates assembly of HIV-1 at the plasma membrane. J Immunol. 2008; 181(5):3706-13. PMC: 2587142. DOI: 10.4049/jimmunol.181.5.3706. View

2.
Guo S, Kemphues K . par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell. 1995; 81(4):611-20. DOI: 10.1016/0092-8674(95)90082-9. View

3.
Raundhal M, Morse C, Khare A, Oriss T, Milosevic J, Trudeau J . High IFN-γ and low SLPI mark severe asthma in mice and humans. J Clin Invest. 2015; 125(8):3037-50. PMC: 4563754. DOI: 10.1172/JCI80911. View

4.
Karelina T, Voronova V, Demin O, Colice G, Agoram B . A Mathematical Modeling Approach to Understanding the Effect of Anti-Interleukin Therapy on Eosinophils. CPT Pharmacometrics Syst Pharmacol. 2016; 5(11):608-616. PMC: 5192997. DOI: 10.1002/psp4.12129. View

5.
Jackson D, Makrinioti H, Rana B, Shamji B, Trujillo-Torralbo M, Footitt J . IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med. 2014; 190(12):1373-82. PMC: 4299647. DOI: 10.1164/rccm.201406-1039OC. View